GENE ONLINE|News &
Opinion
Blog

COVID-19
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
Moderna’s Lawsuit Against Pfizer/BioNTech: What Does This Mean for Their Vaccine’s future?
2022-08-26
FDA Removes N95 Respirators From the Medical Device Shortage List
2022-08-26
Moderna Follows Pfizer With Their Own Omicron BA.4/BA.5 Application to the FDA
2022-08-24
Pfizer-BioNTech COVID-19 Vaccine Proven Effective in Young Children
2022-08-23
Pfizer and BioNTech’s New Bivalent Omicron Vaccine Lined Up for Authorization from the FDA
2022-08-22
EMA Begins Review of SK biosciences’ New Non-mRNA COVID-19 vaccine
2022-08-18
Despite Global Acceptance, The UK Refuses to Buy AstraZeneca’s Evusheld, Citing ‘Insufficient Data’
2022-08-16
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
MHRA Grants Moderna’s Omicron Bivalent Vaccine Conditional Approval in UK
2022-08-15
Novel Inhalable COVID-19 Therapeutic Targeting Viral Replication
2022-08-10
European Commision Purchases an additional 15 million Moderna Bivalent COVID-19 Vaccines
2022-08-09
Moderna to Supply 66 Million COVID-19 Boosters to US
2022-07-29
EMA Begins Reviewing Cancer Medicine for COVID-19 Without Manufacturer’s Application
2022-07-28
Monoclonal Antibody Discovered to Potentially Act Against All Coronaviruses
2022-07-25
1 2 3 4 25
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top